AGL - Agilon Health, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$53.20
DETAILS
HIGH:
$81.00
LOW:
$16.00
MEDIAN:
$49.00
CONSENSUS:
$53.20
DOWNSIDE:
55.39%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 5,932.6 | 6,060.5 | 4,316.4 | 2,388.2 | 1,521.5 | 1,218.3 | 794.4 |
| Cost of Revenue | 6,121.2 | 6,055.7 | 4,246.7 | 2,276.9 | 1,455.8 | 1,124.2 | 765.9 |
| Gross Profit | (188.6) | 4.8 | 69.7 | 111.4 | 65.7 | 94.2 | 28.5 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 238.5 | 268.9 | 285.8 | 207.8 | 427.5 | 137.3 | 122.8 |
| Other Expenses | (6.1) | 28.1 | 16.0 | 8.9 | 10.5 | 13.5 | 12.3 |
| Operating Expenses | 232.5 | 297.0 | 301.8 | 216.7 | 438.0 | 150.8 | 135.1 |
| Operating Income | |||||||
| Operating Income | (421.1) | (292.1) | (232.1) | (105.4) | (372.2) | (56.7) | (106.6) |
| Interest Expense | 6.6 | 6.2 | 6.7 | 4.5 | 6.1 | 8.1 | 9.1 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (368.9) | (218.2) | (167.6) | (72.4) | (362.2) | (40.1) | (64.2) |
| EBIT | (397.5) | (242.6) | (187.8) | (86.2) | (376.8) | (54.2) | (105.6) |
| Income Before Tax | (404.1) | (248.8) | (194.5) | (90.7) | (383.0) | (62.3) | (114.7) |
| Income Tax Expense | 1.3 | 1.5 | 0.8 | 1.6 | 0.9 | 0.9 | (0.2) |
| Net Income | (405.3) | (260.2) | (262.6) | (106.6) | (406.5) | (60.1) | (282.6) |
| Per Share Data | |||||||
| EPS (Basic) | -24.50 | -15.75 | -16.00 | -6.50 | -27.25 | -4.00 | -18.50 |
| EPS (Diluted) | -24.50 | -15.75 | -16.00 | -6.50 | -27.25 | -4.00 | -18.50 |
| Shares Outstanding | 16.6 | 16.4 | 16.4 | 16.3 | 14.9 | 15.4 | 15.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 173.7 | 193.9 | 114.3 | 465.3 | 1,054.8 | 106.8 | 123.6 |
| Short-Term Investments | 111.4 | 211.7 | 380.8 | 411.9 | 0 | 0 | 0 |
| Net Receivables | 673.8 | 1,017.0 | 942.5 | 492.4 | 293.4 | 144.6 | 93.3 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 137.8 | 35.1 | 42.5 | 81.7 | 19.0 | 33.2 | 24.3 |
| Total Current Assets | 1,096.7 | 1,457.8 | 1,480.1 | 1,451.3 | 1,367.2 | 294.2 | 245.5 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 25.4 | 37.0 | 41.0 | 32.0 | 20.9 | 16.0 | 18.8 |
| Goodwill | 0 | 24.1 | 24.1 | 2.5 | 41.5 | 41.5 | 41.5 |
| Intangible Assets | 65.7 | 72.8 | 63.8 | 18.4 | 55.4 | 60.5 | 71.1 |
| Long-Term Investments | 59.8 | 61.8 | 44.8 | 17.4 | 6.7 | 8.5 | 0 |
| Other Non-Current Assets | 23.7 | 80.6 | 87.1 | 175.9 | 94.5 | 25.6 | 25.7 |
| Total Non-Current Assets | 174.6 | 276.2 | 260.8 | 246.2 | 219.1 | 152.2 | 157.3 |
| Total Assets | 1,271.3 | 1,734.0 | 1,740.9 | 1,697.5 | 1,586.3 | 446.4 | 402.8 |
| Current Liabilities | |||||||
| Account Payables | 1,057.2 | 1,149.5 | 968.1 | 478.2 | 348.7 | 260.1 | 188.3 |
| Short-Term Debt | 19.2 | 2.5 | 9.1 | 5 | 8.3 | 3.0 | 3.0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 51.9 | 0 | 3.7 | 8.3 |
| Total Current Liabilities | 1,076.5 | 1,152.0 | 977.2 | 535.1 | 357.0 | 266.8 | 199.6 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 15.8 | 34.9 | 32.3 | 38.5 | 43.4 | 64.7 | 67.1 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 10.0 | 12.8 |
| Other Non-Current Liabilities | 50.5 | 69.5 | 59.5 | 74.2 | 86.4 | 384.1 | 347.5 |
| Total Non-Current Liabilities | 68.1 | 111.0 | 102.7 | 121.8 | 137.7 | 464.3 | 435.2 |
| Total Liabilities | 1,144.6 | 1,263.0 | 1,079.8 | 656.9 | 494.7 | 731.1 | 634.8 |
| Stockholders' Equity | |||||||
| Common Stock | 4.1 | 4.1 | 4.1 | 4.1 | 4.0 | 2.5 | 2.5 |
| Retained Earnings | (1,978.3) | (1,587.0) | (1,326.8) | (1,064.2) | (957.7) | (551.2) | (491.1) |
| Accumulated Other Comprehensive Income | 0.9 | (0.1) | (2.3) | (5.6) | 0 | 0 | 0 |
| Total Stockholders' Equity | 126.7 | 471.0 | 661.8 | 1,041.2 | 1,091.9 | (284.7) | (232.0) |
| Total Liabilities & Equity | 1,271.3 | 1,734.0 | 1,740.9 | 1,697.5 | 1,586.3 | 446.4 | 402.8 |
| Debt Metrics | |||||||
| Total Debt | 36.8 | 44.0 | 52.3 | 52.6 | 59.6 | 73.2 | 77.9 |
| Net Debt | (136.9) | (149.9) | (62.0) | (412.7) | (995.2) | (33.6) | (45.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (391.3) | (260.1) | (262.8) | (106.9) | (406.8) | (60.1) | (282.7) |
| Depreciation & Amortization | 28.6 | 24.5 | 20.2 | 13.8 | 14.7 | 14.1 | 41.4 |
| Stock-Based Compensation | 49.1 | 50.7 | 69.3 | 28.4 | 292.4 | 6.7 | 5.2 |
| Change in Working Capital | 189.5 | 130.6 | (10.1) | (59.4) | (55.0) | 6.5 | 33.2 |
| Other Non-Cash Items | 18.4 | (3.4) | 27.2 | (7.2) | 9.8 | (17.6) | 115.2 |
| Operating Cash Flow | (105.8) | (57.8) | (156.2) | (130.8) | (148.2) | (53.2) | (103.9) |
| Investing Activities | |||||||
| Capital Expenditure | (13.2) | (13.3) | (30.8) | (32.7) | (13.4) | (2.4) | (3.9) |
| Acquisitions | 0 | 0 | (43.1) | 0.5 | (1.3) | 26.2 | 0 |
| Purchases of Investments | (60.2) | (12.0) | (114.7) | (458.3) | (7.1) | (2.1) | 0 |
| Sales/Maturities of Investments | 193.9 | 206.9 | 164.0 | 52.5 | 7.1 | 2.1 | 0 |
| Other Investing Activities | (31.9) | (41.8) | (34.5) | (23.7) | (75.7) | (1.8) | (1.2) |
| Investing Cash Flow | 88.6 | 139.9 | (44.0) | (444.4) | (90.5) | 22.1 | (5.1) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | (3.8) | (5) | (5) | (19.9) | (3.0) | (3.6) |
| Stock Repurchased | (3.0) | 0 | (200) | 0 | 0 | (6.7) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 11.9 | 0 | (14.7) | 0 | (0.3) |
| Financing Cash Flow | (3.0) | (2.6) | (193.1) | 28.1 | 1,154.4 | 24.6 | 176.3 |
| Cash Position | |||||||
| Net Change in Cash | (20.1) | 79.5 | (393.4) | (547.1) | 915.7 | (6.5) | 67.4 |
| Cash at Beginning | 193.9 | 114.3 | 507.7 | 1,054.8 | 139.1 | 145.6 | 78.2 |
| Cash at End | 173.7 | 193.9 | 114.3 | 507.7 | 1,054.8 | 139.1 | 145.6 |
| Free Cash Flow | (119.0) | (71.0) | (187.0) | (163.5) | (161.6) | (55.6) | (107.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 5,932.6 | 6,060.5 | 4,316.4 | 2,388.2 | 1,521.5 | 1,218.3 | 794.4 |
| Gross Profit | (188.6) | 4.8 | 69.7 | 111.4 | 65.7 | 94.2 | 28.5 |
| Operating Income | (421.1) | (292.1) | (232.1) | (105.4) | (372.2) | (56.7) | (106.6) |
| Net Income | (405.3) | (260.2) | (262.6) | (106.6) | (406.5) | (60.1) | (282.6) |
| EPS (Diluted) | -24.50 | -15.75 | -16.00 | -6.50 | -27.25 | -4.00 | -18.50 |
| Balance Sheet | |||||||
| Cash & Equivalents | 173.7 | 193.9 | 114.3 | 465.3 | 1,054.8 | 106.8 | 123.6 |
| Total Assets | 1,271.3 | 1,734.0 | 1,740.9 | 1,697.5 | 1,586.3 | 446.4 | 402.8 |
| Total Debt | 36.8 | 44.0 | 52.3 | 52.6 | 59.6 | 73.2 | 77.9 |
| Stockholders' Equity | 126.7 | 471.0 | 661.8 | 1,041.2 | 1,091.9 | (284.7) | (232.0) |
| Cash Flow | |||||||
| Operating Cash Flow | (105.8) | (57.8) | (156.2) | (130.8) | (148.2) | (53.2) | (103.9) |
| Capital Expenditure | (13.2) | (13.3) | (30.8) | (32.7) | (13.4) | (2.4) | (3.9) |
| Free Cash Flow | (119.0) | (71.0) | (187.0) | (163.5) | (161.6) | (55.6) | (107.8) |